Atom Grants
Discover
  • Dashboard
  • Search
  • Deep Research
  • Favorites
  • Projects

    Research on Complex Generics

    FDA funds research on complex generics to expand access to safe, effective generic medicines and reduce drug shortages through a more competitive, multi-sourced U.S. market.

    OverviewSimilar Grants
    OverviewSimilar Grants

    Center for Research on Complex Generics (U18) Clinical Trials Optional

    FDA grant to fund a center researching complex generics, fostering collaboration between the FDA, industry, academia, and the public to improve access to generic drugs.

    HHS-FDA$1,500,000Forecasted

    Collaborations to Enhance Drug Development and Regulatory Science

    FDA grant supports collaborative projects to advance drug development, manufacturing, and regulatory science, focusing on safety, efficacy, and innovation.

    HHS-FDA$5,000,000Forecasted

    Repurposing Generic (ReGen) Drugs Evidence Package Challenge

    Repurposing Generic (ReGen) Drugs Evidence Package Challenge supports individuals, teams, and entities developing evidence for new generic drug uses in high-cost conditions to advance access to affordable treatments.

    NIH ChallengesDue Jan 15, 2027$100,000

    Utilizing Real-World Data and Algorithmic Analyses to Assess Post-Market Clinical Outcomes in Patients Switching Amongst Therapeutically Equivalent Complex Generic Drug Products and Reference Listed Drugs (U01) Clinical Trial Not Allowed

    This grant seeks to develop AI/ML models using real-world data to monitor clinical outcomes when patients switch between complex generics and brand-name drugs.

    HHS-FDA$300,000Forecasted

    Policy Research Grants

    Policy Research Grants support researchers conducting health policy studies that inform public and private strategies to improve health care affordability, access, quality, and value in the United States.

    NIHCMForecasted Jun 8, 2027$50,000Forecasted